Concordance between tissue and circulating tumor DNA (ctDNA) testing for neurotrophic tyrosine receptor kinase ( NTRK) gene fusions in larotrectinib (laro) clinical trials

被引：1
|
作者：
Rudzinski, Erin R.
Ladanyi, Marc
Ritterhouse, Lauren L.
Sahm, Felix
Norenberg, Ricarda
Zheng, Hong
Chen, Chi
Bernard-Gauthier, Vadim
Brega, Nicoletta
Van Tilburg, Cornelis M.
Lin, Jessica J.
Brose, Marcia S.
Lassen, Ulrik N.
McDermott, Ray
Laetsch, Theodore W.
Hong, David S.
Drilon, Alexander
Roy-Chowdhuri, Sinchita
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT228
引用
收藏
页数：3
相关论文
共 21 条
  • [1] Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion Testing in Clinical Trials of Larotrectinib
    Rudzinski, E.
    Hong, D.
    Rudolph, M.
    Lockwood, C.
    Reeves, J.
    Moh, A.
    Nogai, H.
    Laetsch, T.
    Drilon, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S79 - S79
  • [2] Genomic testing approaches used to identify neurotrophic tyrosine receptor kinase (NTRK) gene fusions for patient enrollment in clinical trials of larotrectinib
    Hechtman, J.
    Roy-Chowdhuri, S.
    Rudolph, M.
    Lockwood, C. M.
    Silvertown, J.
    Wierzbinska, J.
    Norenberg, R.
    Nogai, H.
    Laetsch, T. W.
    Hong, D. S.
    Drilon, A.
    Rudzinski, E. R.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S39 - S40
  • [3] Pan-tumor analyses of kinase fusions detected in circulating tumor DNA (ctDNA) and concordance with paired tissue.
    Lee, Jessica Kim
    Lieber, Daniel
    Madison, Russell
    Chung, Jon
    Schrock, Alexa Betzig
    Creeden, James
    Venstrom, Jeffrey
    Alexander, Brian Michael
    Hazar-Rethinam, Mehlika
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Genomic concordance between profiling of circulating tumor DNA (ctDNA) and matched tissue in metastatic urothelial carcinoma.
    Vandekerkhove, Gillian
    Lavoie, Jean-Michel
    Annala, Matti
    Sundahl, Nora
    Sano, Takeshi
    Struss, Werner J.
    Todenhofer, Tilman
    Ost, Piet
    Chi, Kim N.
    Black, Peter C.
    Eigl, Bernhard J.
    Wyatt, Alexander William
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [5] EGFR mutations in circulating tumor DNA (ctDNA) and tissue rebiopsy at progression on treatment with EGFR tyrosine kinase inhibitors (TKI)
    Mohorcic, K.
    Kern, I.
    Rot, M.
    Cufer, T.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S123 - S123
  • [6] Meta-analyses on mutation status concordance between tumor tissue and circulating tumor DNA and prognostic value of ctDNA in pancreatic cancer
    Popova, A.
    Fedyanin, M.
    Pokataev, I.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S178 - S178
  • [7] CHALLENGES OF DESCRIPTIVE EPIDEMIOLOGY IN RARE DISEASES: A SYSTEMATIC LITERATURE REVIEW (SLR) AND META-ANALYSIS (MA) OF SOLID TUMORS WITH NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) GENE FUSIONS
    Anna, F.
    Zhang, W. W.
    Strauss, U. P.
    Fellous, M.
    Korei, M.
    Keating, K. N.
    VALUE IN HEALTH, 2020, 23 : S454 - S454
  • [8] CLINICAL OUTCOMES OF PATIENTS WITH NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) GENE FUSION CANCER TREATED WITH NON-TROPOMYOSIN RECEPTER KINASE INHIBITORS: A SYSTEMATIC LITERATURE REVIEW
    Pan, X.
    Jiao, X.
    Ruiz, K.
    Stewart, F.
    Kistler, K.
    Patel, R.
    Zong, J.
    Bernard-Gauthier, V
    VALUE IN HEALTH, 2022, 25 (12) : S50 - S50
  • [9] The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers.
    Tie, Jeanne
    Wang, Yuxuan
    Tomasetti, Cristian
    Li, Lu
    Springer, Simeon
    Kinde, Isaac
    Wong, Rachel
    Kosmider, Suzanne
    Tran, Ben
    Desai, Jayesh
    Hayes, Theresa M.
    Haydon, Andrew Mark
    Yip, Desmond
    Christie, Michael
    Strausberg, Robert
    Diaz, Luis A.
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Assessment of circulating cell-free tumor DNA (ctDNA) in 847 patients (pts) with metastatic renal cell carcinoma (mRCC) and concordance with tissue-based testing
    Zengin, Z. B.
    Weipert, C.
    Hsu, J.
    Salgia, N.
    Saam, J.
    Choueiri, T. K.
    Agarwal, N.
    Pal, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S553 - S554
123